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July 2010254 Abstractsevents or cerebrovascular events, there were no differences between patients
with symptomatic and asymptomatic PAD. Secondary prevention is recom-
mended in the current American Heart Association/American College of
Cardiology guidelines on PAD. Recommendations do not differentiate
between symptomatic and asymptomatic PAD patients. The current study
supports this approach and suggests adoption of secondary prevention
methods for patients with asymptomatic PAD as detected only by a de-
creased ABI.
Natural History of Syphilitic Aortitis
Roberts WC, Ko JM, Vowels TJ. Am J Cardiology 2009;104:1578-87.
Conclusion: Cardiovascular syphilis is still present. A serologic test for
syphilis is recommended in patients with dilated ascending aortas irrespec-
tive of whether or not they have aortic regurgitation.
Summary: In the 19th century, 15% of the adult population in the
United States was afflicted by syphilis. Syphilology was a separate medical
specialty devoted to the treatment of the manifestations of this disease. It is
infrequent for patients with primary syphilis to develop tertiary syphilis.
Syphilis is a difficult disease to study in that the spirochete Treponema
pallidum cannot be convincingly demonstrated in histologic sections of the
aorta in patients with dilated aortas presumably secondary to tertiary syphilis.
In addition T pallidum cannot be cultured. There have been no large studies
of cardiovascular syphilis since 1964. In this well-illustrated study, the
authors present results of autopsies in 90 patients with characteristic mor-
phologic findings of syphilitic aortitis. All but two patients were examined by
a single author from 1966 to 1990. All 90 patients had extensive involve-
ment of the ascending aorta by the syphilitic process. The sinus of Valsalva
was spared in all but four patients. In 26% of the 90 patients, syphilis was the
cause of death in patients in whom the aortic arch and descending thoracic
aorta were examined. There was evidence of syphilitic involvement of the
aortic arch in 49 of 54 patients (91%) and syphilitic involvement of the
descending thoracic aorta in 47 of 52 patients (90%). In the 23 patients who
died, death was secondary to rupture of the ascending or descending
thoracic aorta in 12 and form severe aortic regurgitation in 10. One patient
had severe narrowing of the osteum of the right coronary artery as the cause
of death. Serologic testing for syphilis was performed in 40 patients and 28
(70%) had a positive finding. Patients with negative or nonreactive tests who
did not undergo serologic tests for syphilis had histologic and morphologic
findings in the aorta at autopsy similar to the finding in the patients who had
positive serologic tests.
Comment: The paper is a fascinating review of the aortic manifesta-
tions of tertiary syphilis. Key points are that syphilis still occurs in the general
population. Seventy-seven of the 90 cases in this series were from Washing-
ton, DC-area hospitals or institutions. Men outnumbered women 2:1. The
series also serves to remind us that a negative serologic test does not exclude
the presence of syphilis. As vascular surgeons become more involved in the
treatment of patients with thoracic aortic disease, including the development
of hybrid procedures to treat aortic arch disease, it will be necessary to keep
in mind that the underlying etiology of the disease may in some cases still be
tertiary syphilis.
Are Plasma Renin Activity and Aldosterone Levels Useful as a Screen-
ing Test to Differentiate Between Unilateral and Bilateral Renal Artery
Stenosis in Hypertensive Patients?
Kotiliar C, Inserra F, Forcada P, et al. J Hypertension 2010;28:594-601.Conclusion: Serum aldosterone levels, plasma renin activity, and aldo-
sterone plasma renin (Ald/PRA) ratios are significantly different in patientswith unilateral renal artery stenosis versus bilateral renal artery stenosis and
from patients with essential hypertension.
Summary: The aldosterone to plasma renin activity ratio (Ald/
PRA) is a common screening test for hyperaldosteronism as a secondary
cause of hypertension in patients with resistant hypertension (Current
Hypertension Reports 2007;9:353-9). The Ald/PRA ratio, however, is not
currently used for diagnosis of RAS. There are no reports comparing
renin-angiotensin-aldosterone system status between patients with unilat-
eral RAS and those with bilateral RAS. This paper sought to evaluate the
relationship between aldosterone levels and plasma renin activity as surro-
gate markers of renin-angiotensin-aldosterone system status in patients with
unilateral RAS and those with bilateral RAS. The second objective was to
determine the usefulness of the Ald/PRA ratio as a noninvasive test contrib-
uting to the differential diagnosis of unilateral versus bilateral RAS.
There were 708 hypertensive patients studied. Based on Mann and
Pickering recommendations (Ann Intern Med 1992;117:845-53), pa-
tients at intermediate and high-risk of RAS were selected to undergo
renal gadolinium-enhanced magnetic resonance angiography and arteriog-
raphy. There were 66 patients in this group; 15 were excluded by diabetes or
a low glomerular filtration rate. After consideration of the imaging studies,
there were 51 hypertensive patients who were then studied, 16 with unilat-
eral RAS, 16 with bilateral RAS, and 19 essential hypertensive patients with
no evidence of RAS. Unilateral RAS was defined as lumen reduction 70%
in one renal artery. Bilateral RAS was defined as the combination of at least
70% RAS in one renal artery and 50% RAS in the contralateral renal artery.
Normal arteries were those with no lumen narrowing or lumen reductions of
less than 30%. There were 19 normotensive individuals also included in the
study. Aldosterone and plasma renin activities were reported at baseline and
after stenosis resolution in those patients who underwent angioplasty and
stenting.
Ald/PRA ratios (ng/dL per (ng/mL per h1)) were higher in bilateral
RAS (5.92 2.30; P .001) and lower in unilateral RAS (0.38 0.17; P
.001) versus those patients with essential hypertension (1.52 2.02). When
the Ald/PRA ratio was 3.6, multilevel likelihood ratios were positive for
bilateral RAS. When the ratio was0.2, the likelihood ratio was negative for
bilateral RAS. When the Ald/PRA ratio was between 0.2 and 3.6, the
likelihood ratio for bilateral RAS was neutral. Receiver operator character-
istic curve analysis identified an aldosterone/plasma renin activity0.5 and
Ald/PRA3.7 to have the best sensitivity and specificity to detect unilateral
RAS and bilateral RAS, respectively. Following intervention, plasma renin
activity was significantly lower than basal renal activity in patients with
unilateral RAS but not in those with bilateral RAS. In patients with unilateral
RAS, postintervention aldosterone levels were approximately 30% of base-
line, while in patients with bilateral RAS postintervention aldosterone levels
were approximately three times lower than baseline. There were no differ-
ences in plasma renin activity and aldosterone levels over time in patients
with essential hypertension.
Comment: The study suggests its patients can be categorized accord-
ing to unilateral or bilateral RAS on the basis of Ald/PRA ratios. When the
Ald/PRA ratio is0.5, the patient will likely have unilateral RAS. When the
Ald/PRA ratio is more than 3.7, bilateral RAS is likely. There is also a gray
area of ratios between 0.5 and 3.7 that do not clearly differentiate hyperten-
sive patients with unilateral and bilateral RAS, and many of these patients will
have essential hypertension. A patient suspected of renal vascular hyperten-
sion potentially could be screened with Ald/PRA ratios. If the ratio is
between 0.5 and 3.7, noninvasive testing to evaluate for potential RAS is
indicated. Some will actually end up having RAS but most will not. How-
ever, when the ratio is0.5 or3.7, and one does not believe the ASTRAL
trial (N Engl J Med 2009;361:1953-62), one might consider moving
directly to a catheter-based study, as it is highly likely 70% RAS will be
found in at least one renal artery.
